Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	329.96	216.44	222.28	269.57	300.61	195.25
Cash & Short-Term Investments	329.96	216.44	222.28	269.57	300.61	195.25
Cash Growth	54.11%	-2.63%	-17.54%	-10.33%	53.96%	31.37%
Accounts Receivable	156.57	92.81	194.67	248.37	301.49	379.88
Other Receivables	17.31	25.01	13	9	10.86	16.13
Receivables	173.88	117.82	207.67	257.37	312.34	396.01
Inventory	634.83	717.94	969	1,211	819.95	753.85
Prepaid Expenses	15.71	6.69	42.28	49.82	16.08	11.97
Total Current Assets	1,154	1,059	1,441	1,788	1,449	1,357
Property, Plant & Equipment	1,985	2,061	2,199	2,292	1,964	1,868
Long-Term Investments	1,074	1,053	1,002	994.48	998.25	1,060
Other Intangible Assets	1.04	1.54	3.77	5.56	7.53	1.8
Long-Term Deferred Tax Assets	42.34	52.28	35.55	20.44	20.14	24.48
Other Long-Term Assets	102.74	90.65	80.91	71.27	125.42	69.35
Total Assets	4,359	4,317	4,763	5,172	4,564	4,381

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	28.69	30.25	41.44	104.36	144.33	78.77
Accrued Expenses	42.63	47.42	67.25	122.22	193.56	143.72
Short-Term Debt	150	200	150	500	100	150
Current Portion of Leases	1.82	1.78	2.91	3.36	2.54	1.32
Current Income Taxes Payable	1.5	0.12	1.82	10.59	49.98	31.05
Current Unearned Revenue	18.43	52.92	124.31	15.91	53.95	73.99
Other Current Liabilities	41.07	24.21	37.56	74.97	69.83	156.34
Total Current Liabilities	284.14	356.71	425.29	831.41	614.18	635.17
Long-Term Debt	600	600	700	700	500	600
Long-Term Leases	1.89	2.79	3.98	4.47	0.72	1.02
Long-Term Unearned Revenue	1.2	3.5	12.74	27	-	-
Long-Term Deferred Tax Liabilities	268.98	267.02	263.79	258.54	256.22	250.3
Total Liabilities	1,156	1,230	1,406	1,821	1,371	1,486

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	769.18	769.18	775.6	775.6	775.6	775.6
Additional Paid-In Capital	331.76	331.76	334.53	334.53	334.32	334.32
Retained Earnings	2,150	2,042	2,312	2,296	2,129	1,744
Comprehensive Income & Other	-47.95	-55.83	-65.17	-55.48	-46.05	39.76
Total Common Equity	3,203	3,087	3,357	3,350	3,193	2,894
Minority Interest	-	-	-	-	0.19	0.19
Shareholders' Equity	3,203	3,087	3,357	3,350	3,193	2,894
Total Liabilities & Equity	4,359	4,317	4,763	5,172	4,564	4,381

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	753.71	804.57	856.89	1,208	603.26	752.34
Net Cash (Debt)	-423.75	-588.14	-634.61	-938.26	-302.65	-557.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.66	-10.58	-11.27	-12.01	-3.86	-7.11
Filing Date Shares Outstanding	76.92	76.92	77.56	77.56	77.56	77.56
Total Common Shares Outstanding	76.92	76.92	77.56	77.56	77.56	77.56
Working Capital	870.24	702.18	1,016	956.37	834.81	721.91
Book Value Per Share	41.64	40.14	43.28	43.20	41.17	37.31
Tangible Book Value	3,202	3,086	3,353	3,345	3,185	2,892
Tangible Book Value Per Share	41.63	40.12	43.23	43.12	41.07	37.29
Land	1,092	1,092	1,092	1,092	741.4	741.4
Buildings	961.88	954.17	948.27	936.09	900.62	826.11
Machinery	2,521	2,512	2,456	2,389	2,296	2,032
Construction In Progress	12.62	14.8	59.46	48.39	27.85	126.44

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error